Exhibiting at FOOD INGREDIENTS CHINA 2025

Sabinsa Nanjing Biotech Co., Ltd., located in Nanjing, China, operates as the Chinese subsidiary of Sabinsa Corporation, a global leader in nutraceuticals and botanical extracts. Sabinsa was established in 1988 in the United States and is part of the Sami-Sabinsa Group. The Nanjing entity serves as a critical extension for sales, customer support, and technical service across Greater China, while aligning with Sabinsa’s global standards for innovation, safety, and efficacy in natural health ingredients.

Core Business and Product Portfolio

Sabinsa Nanjing Biotech focuses on the promotion, technical support, and regional distribution of scientifically validated natural ingredients developed by its parent company. These ingredients are used in nutraceuticals, functional foods, dietary supplements, cosmetics, and pharmaceuticals.

Key Product Lines:

1. Standardized Herbal Extracts:

   • Curcumin C3 Complex®: A highly researched turmeric extract standardized to 95% curcuminoids.
   • ForsLean®: A patented extract from Coleus forskohlii, used for weight management.
   • Boswellin®: Boswellia serrata extract known for joint and anti-inflammatory support.
   • Saberry®: Amla extract standardized for low molecular weight tannins.

2. Probiotics:

   • LactoSpore®: A stable, spore-forming probiotic (Bacillus coagulans MTCC 5856) used in gut health and immunity formulations.

3. Bioavailability Enhancers:

   • BioPerine®: A patented piperine extract from black pepper that enhances nutrient absorption.

4. Cosmeceuticals and Specialty Actives:

   • Ingredients for skin brightening, anti-aging, and dermal protection applications.

All products are backed by scientific studies and are available with complete documentation including CoA, MSDS, technical dossiers, and clinical research summaries.

Specialisation and Core USP

Sabinsa Nanjing’s competitive strengths are inherited from the global Sabinsa ecosystem:

• Science-Based Innovation: Over 300 scientists globally, including 120+ with PhDs, engaged in research and formulation.
• Patented Ingredients: Holds more than 400 granted patents worldwide and several pending applications.
• Vertically Integrated Supply Chain: From farm to formulation, ensuring traceability, quality control, and sustainability.
• Clinically Validated: Products like Curcumin C3 Complex®, BioPerine®, and LactoSpore® are among the most researched in their categories.

The company’s formulation support, IP protection, and data-driven ingredient marketing make it a top-tier partner for nutraceutical brands.

Certifications and Compliance

Sabinsa’s manufacturing and product standards are globally recognized. The Nanjing branch ensures regional compliance and supports exports aligned with the following certifications:

• ISO 9001, ISO 22000, and NSF GMP certified facilities (via parent company)
• FSSC 22000 Food Safety System Certification
• Halal and Kosher Certified
• Non-GMO, GRAS Status, and Allergen-Free Declarations
• Compliance with China Food and Drug Administration (CFDA) and National Food Safety Standards (GB)

The company is committed to regulatory transparency and facilitates documentation for novel food filings and health food registrations in China.

Target Market

Sabinsa Nanjing serves a wide array of industries:

• Dietary Supplement Manufacturers
• Functional Food and Beverage Companies
• Cosmeceutical and Derma Brand Owners
• Pharmaceutical Industry
• Traditional Chinese Medicine (TCM) formulators seeking standardized actives

Its clientele ranges from multinational nutraceutical brands to local health product developers seeking premium botanical ingredients.

Capabilities

• Technical Consultation: In-house application specialists provide assistance in formulation and dosage optimization.
• Documentation Support: Complete regulatory and scientific documentation packages available for each ingredient.
• Supply Chain Management: Backed by global logistics infrastructure for timely and compliant deliveries.
• R&D Collaboration: Offers joint development and clinical research collaboration for China-based innovation.

Sabinsa also supports formulation workshops and educational sessions for clients in China, promoting science-based product development.

Financial Overview

While Sabinsa Nanjing does not release standalone financials, its parent company reports strong global growth. Sabinsa Corporation's global revenue is estimated to exceed USD 150 million annually, with significant contributions from Asia-Pacific operations. The company has reinvested heavily in research and production capacity to meet growing demand for clinically backed, natural ingredients.

The Nanjing office supports this growth by localizing services, reducing lead times, and expanding regional market penetration.

Shipment and Export Records

Based on trade and customs data:

• Sabinsa regularly ships ingredients such as curcumin, piperine, boswellia, and bacillus coagulans to clients in South Korea, Japan, Vietnam, and Thailand via its Nanjing node.
• The company also handles imports of specialty ingredients and analytical reagents to support QC and formulation labs in China.
• Ingredients are packed in pharma-grade HDPE drums and vacuum-sealed foil pouches, ensuring shelf stability and potency during shipment.

Their supply chain model enables traceable, just-in-time shipments and ensures high customer satisfaction in ingredient sourcing.

Achievements

• Patented over 400 nutraceutical ingredients and delivery systems globally.
• LactoSpore® and BioPerine® featured in more than 100 peer-reviewed publications.
• Received multiple awards including Frost & Sullivan Best Practices, Nutraceutical Business & Technology Awards, and Nutraceuticals World Top Supplier Recognition.
• Successfully supported health food registrations for over a dozen Chinese clients using Sabinsa ingredients.

Sabinsa Nanjing Biotech Co., Ltd. stands as a cornerstone for evidence-based nutraceutical innovation in China, delivering clinically proven, patent-protected, and regulatory-compliant health ingredients to a growing and discerning wellness market.